Cambridge Investment Research Advisors, Inc. Novo Cure LTD Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$40.29 - $82.51 $32,514 - $66,585	807 Added 15.45%	6,029 $250,000
Q1 2023 May 11, 2023	BUY	$56.44 - $118.81 $9,312 - $19,603	165 Added 3.26%	5,222 $314,000
Q4 2022 Feb 08, 2023	SELL	$63.98 - $85.37 $19,961 - $26,635	-312 Reduced 5.81%	5,057 $371,000
Q3 2022 Oct 17, 2022	SELL	$67.99 - $89.57 $1,631 - $2,149	-24 Reduced 0.45%	5,369 $407,000
Q2 2022 Jul 13, 2022	SELL	$56.6 - $89.9 $16,017 - $25,441	-283 Reduced 4.99%	5,393 $374,000
Q1 2022 May 12, 2022	SELL	$60.15 - $84.52 $4,691 - $6,592	-78 Reduced 1.36%	5,676 $470,000
Q4 2021 Feb 03, 2022	BUY	$75.08 - $121.99 $6,306 - $10,247	84 Added 1.48%	5,754 $432,000
Q3 2021 Nov 02, 2021	SELL	$116.17 - $194.55 $3,485 - $5,836	-30 Reduced 0.53%	5,670 $658,000
Q2 2021 Aug 10, 2021	SELL	$130.4 - $225.58 $67,025 - $115,948	-514 Reduced 8.27%	5,700 $1.26 Million
Q1 2021 May 07, 2021	SELL	$124.11 - $190.17 $28,172 - $43,168	-227 Reduced 3.52%	6,214 $821,000
Q4 2020 Feb 04, 2021	SELL	$112.16 - $174.14 $77,726 - $120,679	-693 Reduced 9.71%	6,441 $1.11 Million
Q3 2020 Oct 29, 2020	BUY	$58.05 - $111.31 $26,064 - $49,978	449 Added 6.72%	7,134 $794,000
Q2 2020 Jul 27, 2020	BUY	$57.2 - $74.41 $23,852 - $31,028	417 Added 6.65%	6,685 $396,000
Q1 2020 May 08, 2020	BUY	$57.05 - $95.75 $205,836 - $345,466	3,608 Added 135.64%	6,268 $422,000
Q4 2019 Feb 04, 2020	BUY	$68.3 - $93.8 $181,678 - $249,508	2,660 New	2,660 $224,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$215 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$210 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$140 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$76.4 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$53.7 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account